Cutaneous Myelofibrosis With JAK2 V617F Mutation: Metastasis, Not Merely Extramedullary Hematopoiesis!

被引：11

作者：

Fraga, Garth R. ^{[1
]}

Caughron, Samuel K. ^{[2
]}

机构：

[1] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA

[2] MAWD Pathol Grp, Kansas City, MO USA

来源：

AMERICAN JOURNAL OF DERMATOPATHOLOGY | 2010年 / 32卷 / 07期

关键词：

myelofibrosis; extramedullary hematopoiesis; metastasis; JAK2; leukemia; MYELOID METAPLASIA; IDIOPATHIC MYELOFIBROSIS; SKIN; MANIFESTATION; PATHOGENESIS;

D O I：

10.1097/DAD.0b013e3181d3ca2f

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm. There are 31 reported cases of cutaneous involvement by PMF, most of which have been described as "extramedullary hematopoiesis.'' We report a new case of cutaneous involvement by PMF and demonstrate mutation of the Janus kinase 2 gene in the cutaneous lesions. Extramedullary myelofibrosis is best considered a metastatic phenomenon. Reporting such cases as extramedullary hematopoiesis may cause confusion with reactive forms of extramedullary hematopoiesis.

引用

页码：727 / 730

页数：4

共 50 条

[21] JAK2 V617F, MPL W515L and JAK2 exon 12 mutations in Chinese patients with primary myelofibrosis
Xia, Jun
Lu, Mi-ze
Jiang, Yuan-qiang
Yang, Guo-hua
Zhuang, Yun
Sun, Hong-li
Shen, Yun-feng
CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (01) : 72 - 76
[22] JAK2 V617F mutation in Iranian patients with myeloproliferative neoplasms: clinical and laboratory findings
Poopak, Behzad
Farshdousti Hagh, Majid
Saki, Najmaldin
Elahi, Fazel
Rezvani, Hamid
Khosravipour, Gelareh
Jahangirpour, Mohammad Ali
Bolouri, Shirin
Golkar, Tolou
Falah, Parviz
TURKISH JOURNAL OF MEDICAL SCIENCES, 2013, 43 (03) : 347 - 353
[23] Clinical relevance of JAK2 (V617F) mutant allele burden
Passamonti, Francesco
Rumi, Elisa
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (01): : 7 - 10
[24] The frequency of JAK2 V617F gen mutation and its associations with whole blood count parameters
Unal, Kubranur
Erdogan, Serpil
Yilmaz, Fatma Meric
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2014, 39 (01): : 93 - 98
[25] Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
Benati, Marco
Montagnana, Martina
Danese, Elisa
De Matteis, Giovanna
Veneri, Dino
Paviati, Elisa
Guidi, Gian Cesare
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (07) : 1005 - 1011
[26] Activated STAT1 and STAT5 transcription factors in extramedullary hematopoietic tissue in a polycythemia vera patient carrying the JAK2 V617F mutation
Meyer, Thomas
Ruppert, Volker
Goerg, Christian
Neubauer, Andreas
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (01) : 117 - 120
[27] Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden
Larsen, Thomas Stauffer
Pallisgaard, Niels
de Stricker, Karin
Moller, Michael Boe
Hasselbalch, Hans Carl
HEMATOLOGY, 2009, 14 (01) : 11 - 15
[28] Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation
Shah, Mithun V.
Patel, Keyur P.
Luthra, Raja
Kanagal-Shamanna, Rashmi
Mehrotra, Meenakshi
Bachegowda, Lohith S.
Champlin, Richard E.
Verstovsek, Srdan
Popat, Uday R.
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (05) : 831 - 835
[29] Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting
Lin, Chien-Yu
Ho, Cheng-Mao
Tamamyan, Gevorg
Yang, Shu-Fen
Peng, Ching-Tien
Chang, Jan-Gowth
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (06) : 838 - 844
[30] The Impact of JAK2 V617 Mutation in Splenomegaly and Reticulin Grade of Idiopathic Myelofibrosis
Khanum, Fatima
Rehman, Aman Ur
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (03): : 507 - 508

← 1 2 3 4 5 →